July 2024 - Page 5 of 13

FridayJul 19, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Announces New Data From Phase III Study of Buntanetap for Early Parkinson’s Disease

The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor activities in Parkinson’s Disease patients Following the announcement of these positive results, the company’s stock price surged by 76% The data revealed that while 12% of Parkinson’s Disease patients showed cognitive decline, buntanetap not only halted this decline but also led to improvements Annovis held a webcast to go over the results in more depth, which is available for replay on the company’s website Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s…

ThursdayJul 18, 2024 2:40 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Capitalizing on High-Potential Opportunities in Energy Sector

GEMXX (OTC: GEMZ), a publicly traded exploration company engaged in gold, gemstones, oil and gas, recently signed a definitive agreement with Latin Energy Partners (“LEP”) to drill four test wells in a promising geological formation in Latin America. “This strategic venture represents a significant milestone in GEMXX’s expansion into the energy sector, highlighting the company’s dedication to diversification, growth and enhancing shareholder value. Latin Energy Partners is a rising independent exploration and production company focused on discovering substantial hydrocarbon reserves in Latin America, an area with significant untapped potential… The drilling of the four test wells is set to begin…

ThursdayJul 18, 2024 10:30 am

Nickel Rush Heats Up in Canada: Opening Doors for Companies Like Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) as Canada Eyes a Top Spot Among Global Producers

Nickel demand is expected to grow at a continually accelerating rate over the coming years and decades By 2040, use in batteries will command 41% of total nickel usage, up from just 7% in 2021 Nickel is considered one of the most strategically vulnerable critical metals in North America or the west Like Canada’s Critical Minerals Infrastructure Fund (“CMIF”), the west has been making increasing efforts to encourage critical metal exploration and extraction Fathom is developing two highly prospective projects in Canada’s Trans-Hudson Corridor in Saskatchewan Fathom has received a new drill permit that allows for up to 60 drill…

ThursdayJul 18, 2024 10:28 am

QualityStocksNewsBreaks – Fathom Nickel Inc.’s (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) New, High-Quality Data Continues to Demonstrate Presence of Significant Magmatic Ni-Cu-Co Deposit at Gochager

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), focused on the exploration for nickel, cobalt and copper in north-central Saskatchewan, has provided the preliminary results from the field exploration program at its 22,000+ ha Gochager Lake Property. The program comprised mapping, prospecting, detailed soil geochemistry analysis and detailed in-field core analysis. Key highlights include the existence of good outcrop exposure within the mapped area, providing the opportunity to collect 50 outcrop samples for whole rock and geochemical analysis and 554 chip samples for pXRF scanning; mineralization of up to 20,647ppm Ni (2.06% Ni), 6,922ppm Cu and 1,295ppm Co, which was noted…

ThursdayJul 18, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction

Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a treatment for ALS via the accelerated approval process The briefing book includes new post-hoc analyses of data from completed clinical trials and addresses comments made by the FDA during a previous meeting in late 2023 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a…

ThursdayJul 18, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Reveals Findings of Hyperion Research Quantum Optimization ROI Study and Announces Nomination for Technology Impact Awards

Majority of surveyed businesses actively engaged in quantum computing anticipate significant returns on investment (“ROI”) from their quantum optimization efforts Survey also highlights a significant increase in quantum adoption, with 21% of respondents either currently employing or planning to integrate quantum technology into production within the next 12 to 18 months D-Wave has been named a finalist in the GameChanger Ambition category of the upcoming Technology Impact Awards (“TIAs”) by the BC Tech Association D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the findings…

WednesdayJul 17, 2024 3:25 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Secures Contract for Juvenile Monitoring, Strengthening Leadership in EM Solutions

SuperCom Ltd. (NASDAQ: SPCB), an identification and digital monitoring solutions company, recently secured a new contract for monitoring juveniles transitioning through California’s justice system. “The case management services will be provided for the California client through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (“LCA”), which provides evidence-based, community-focused services and electronic monitoring programs as a private contractor to government agencies. The California contract reflects a trend worldwide for court and law enforcement advocates to seek privately contracted rehabilitative service and electronic monitoring (‘EM’) solutions providers that allow teen suspects to enjoy a measure of freedom and community integration while…

WednesdayJul 17, 2024 1:05 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at the 73rd Emerging Growth Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company is presenting at the 73rd Emerging Growth Conference, scheduled for July 17-18, 2024. Clene’s presentation is slated to begin at 4:45 p.m. EDT on July 18, with Rob Etherington, Clene’s President and CEO, and Morgan Brown, Clene’s CFO, giving the presentation. To view the full press release, visit https://ibn.fm/Ev3fc About Clene Inc. Clene (along with…

WednesdayJul 17, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Issuance of Three New Patents, Growing Portfolio to 46 Granted Patents Worldwide

Considered intangible assets, patents offer a significant competitive advantage and value for companies Lexaria Bioscience views its growing patent portfolio as a solid foundation upon which to build future commercial partnerships The company recently announced the receipt of three new patents in the E.U., Canada, and the U.S. The issuance of the latest three patents grows Lexaria’s patent portfolio to 46 granted patents worldwide Lexaria’s multi-patented DehydraTECH(TM) “drug delivery platform technology” offers proven increased bioavailability, enhancing the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of…

WednesdayJul 17, 2024 10:24 am

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Enters Strategic Partnership to Support Rollout of Telemedicine Services across the US

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, is announcing a strategic partnership with HC Smart, Inc., a national telemedicine provider. The partnership, set to go live within the next four weeks, is expected to extend HealthLynked’s telemedicine services across the U.S. as well as significantly enhance the company’s offerings and accessibility. The announcement stated that the collaboration will integrate HC Smart’s advanced telemedicine capabilities into HealthLynked’s existing platform, providing nationwide coverage to all HealthLynked members. This initiative will offer HealthLynked Network members access to high-quality healthcare from the comfort of their homes by enabling reduced-cost telemedicine consultations as part…

Site Search

Company Search

Month: July 2024